We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Genetic Marker Found for Nervous System RNA Editing

By Biotechdaily staff writers
Posted on 21 Aug 2003
Researchers have identified a specific DNA sequence that serves as a marker for specific genes targeted for A-to-I RNA editing, a process for modifying messenger RNA and its protein products without causing permanent changes to the organism's genome.

Investigators at the University of Connecticut Health Center (Farmington, CT, USA; www.uchc.edu) used comparative genomics to identify and experimentally verify 16 previously unknown adenosine-to-inosine editing target genes in the fruit fly Drosophila and one in humans. More...
This is more than the sum total previously reported. All of these genes were involved in rapid electrical and chemical neurotransmission. The findings, published in the August 8, 2003, issue of Science, may help scientists to unravel nervous system disorders such as Parkinson's disease and epilepsy.

"The proteins targeted by editing are basically the machinery that allows nervous systems to function on a timescale of milliseconds, which is not a demand placed on every organ,” explained senior author Dr. Robert Reenan, associate professor of genetics and developmental biology at the University of Connecticut. "The literal genome is not the final word and, for whatever reason, this mechanism (A-to-I editing) is almost exclusive to the nervous system.”




Related Links:
University of Connecticut Health Center

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.